Welcome to the e-CCO Library!

P835: Smoking cessation in IBD: What are the predictive factors?
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Martinho-Grueber1*, L. Biedermann2, A. Schöpfer3, S. Vavricka4, C. Clair Willi5, N. Fournier6, M. Allez7, A.J. Macpherson8, P. Juillerat9

Created: Thursday, 21 February 2019, 9:14 AM
P835: Visceral adiposity independently predicts time to flare in inflammatory bowel disease, but BMI does not
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sehgal, P.(1)*;Su, S.(2);Zech, J.(3);Nobel, Y.(1);Luk, L.(3);Economou, I.(4);Shen, B.(4);Kiran, P.(4);Freedberg, D.(1);
Created: Friday, 14 July 2023, 11:12 AM
P836 Biomarkers response to anti-TNF treatment in Crohn’s disease through the intestinal microbiota
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Sanchis1, S. Manresa1, J.F. Martínez2, M. Valls3, M. Iborra4, J.M. Paredes5, M. Boscá6, J.M. Huguet7, R. Gil8, N. Maroto9, J. Rodriguez1, X. Cortés1

Created: Thursday, 30 January 2020, 10:12 AM
P836: Prevalence of anaemia in Italian patients with inflammatory bowel disease: Preliminary results of the observational multi-centre IG-IBD study RIDART 1
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Bergamaschi1, P. Giuffrida1*, W. Fries2, N. Aronico1, R. D'Incà3, M.V. Lenti1, C. Ciacci4, S. Cococcia1, F. Bossa5, G. Ghigliazza1, F. Castiglione6, M.B. Principi7, C. Ricci8, D. Mazzucco9, N. Manetti10, M.L. Scribano11, G. Riegler12, G. Bodini13, G. Bassotti14, F. Monica15, M. Masotti1, P. Vernia16, A. Manca17, A. Buda18, E. Villa19, M. Neri20, M. Comberlato21, A. Testa6, R. Fontana5, P. Iovino4, G.C. Sturniolo3, G.R. Corazza1, A. Di Sabatino1

Created: Thursday, 21 February 2019, 9:14 AM
P836: The predictive role of gut microbiota in treatment response to vedolizumab and ustekinumab in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Caenepeel*1, S. Vieira-Silva2, B. Verstockt1,3, M. Ferrante1,3, J. Raes2, S. Vermeire1,3

Created: Friday, 22 February 2019, 9:41 AM
P836: Trends in the prevalence of Inflammatory Bowel Disease in Lithuania during 2001-2020
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Karpavičiūtė, V.(1)*;Kiudelis, G.(2);Kupčinskas, J.(2);Kupčinskas, L.(2);
Created: Friday, 14 July 2023, 11:12 AM
P837 Changes in the intestinal microbiota of patients with inflammatory bowel disease during an 8-week infliximab infusion cycle
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Seong, J.H. Song, J. Shin, S.M. Kong, E.R. Kim, D.K. Chang, S.N. Hong, Y.H. Kim

Created: Thursday, 30 January 2020, 10:12 AM
P837: Cause and risk factors of death in patients with intestinal Behcet's Disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E.J. Yoo, S.J. Park*, Y. Park, J.H. Cheon, T.I. Kim, W.H. Kim

Created: Thursday, 21 February 2019, 9:14 AM
P837: Incidence, evolution of disease phenotype, time to biological therapy and medium-, long-term surgery rates in IBD-U patients in Western Hungary – a population-based study between 1977–2020, data from the Veszprem county cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gonczi, L.(1)*;Lakatos, L.(2);Golovics, P.A.(3);Pandur, T.(4);David, G.(2);Erdelyi, Z.(2);Szita, I.(2);LakatosPhD, P.L.(5);
Created: Friday, 14 July 2023, 11:12 AM
P837: The common food additives sodium sulfite and polysorbate 80 have a profound inhibitory effect on the commensal, anti-inflammatory bacterium Faecalibacterium prausnitzii: the ENIGMA study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. J. Jimenez Loayza1,2, E. M. Berendsen*1,2, J-J. Teh1,2, E. C. Hoedt1,2,3, J. Zhang4,5, Q. Liu4,5, A. L. Hamilton6, A. Wilson-O'Brien6, G. L. Trakman6, W. Lin4,5, W. Tang4,5, J. Ching4,5, L. M. H. Or4,5, J. J. Sung4,5, J. Yu4,5, S. C. Ng4,5,7, M. A. Kamm6, M. Morrison1,2

Created: Friday, 22 February 2019, 9:41 AM
P838 Characteristics of mucosal microbial composition of patients with inflammatory bowel disease susceptibility HLA genotype
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Hirano, J. Umeno, T. Torisu

Created: Thursday, 30 January 2020, 10:12 AM
P838: Complicated disease in East Asian patients with ulcerative colitis over two decades: A single-centre retrospective cohort in Japan
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Taida1*, J. Kumagai1, S. Ogasawara1, Y. Ohta1, S. Hamanaka1, M. Nakamura1, H. Ohyama1, K. Saito1, Y. Kusakabe1, S. Yasui1, H. Sugiyama1, Y. Sakai1, R. Mikata1, T. Nakagawa1, T. Katsuno2, T. Tsuyuguchi1, N. Kato1

Created: Thursday, 21 February 2019, 9:14 AM
P838: Effects of microbial metabolites on human intestinal epithelium
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Mayorgas*1, E. Ferrer-Picón1, I. Dotti1, A. Corraliza1, N. Planell2, M. Esteller1,2, A. Carrasco2,3, M. C. Masamunt1, M. Esteve2,3, J. Panés1, A. Salas1

Created: Friday, 22 February 2019, 9:41 AM
P838: Increased Risk of Avascular Necrosis in Patients With Inflammatory Bowel Disease: a nationwide population based cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Moon, J.M.(1)*;Kwon, K.E.(2);Jung, S.Y.(2);Choi, C.H.(1);Lee, J.W.(2);Shin, S.Y.(1);Joo, H.J.(1);
Created: Friday, 14 July 2023, 11:12 AM
P839 Analysis of mucosa-associated microbiota and serum cytokines levels in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Fukushima1, A. Shiotani1, H. Matsumoto1, R. Inoue2, Y. Naito3

Created: Thursday, 30 January 2020, 10:12 AM
P839: Clinical activity in inflammatory bowel diseases is associated with consumption of processed foods
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sarbagili Shabat, C.(1,2)*;Zelber-Sagi, S.(1,3);Fliss Isakov, N.(1);Hirsch, A.(1); Ron, Y.(1);Thurm, T.(1);Maharshak, N.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P839: Clinical and sociodemographical characteristics of inflammatory bowel disease in Mexico: Multicentric nation-wide study (EPIMEX-IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Yamamoto-Furusho1*, A. Sarmiento1, J. Toledo-Mauriño1, K. Bozada-Gutiérrez1, F. Bosques-Padilla2, M. Martínez-Vázquez3, V. Marroquín-Jiménez4, R. García-Figueroa5, C. Jaramillo-Buendía6, R. Miranda-Cordero7, J. Valenzuela-Pérez8, Y. Cortes-Aguilar9, J. Jacobo-Karam10, E. Bermudez-Villegas11, E. Study Group12

Created: Thursday, 21 February 2019, 9:14 AM
P840 Immunomodulatory effects of two different postbiotics on primary human cell culture
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Mayorgas

Created: Thursday, 30 January 2020, 10:12 AM
P840: Dietary interventions rapidly alter metabolomics profile of patients with inflammatory bowel disease after pouch surgery
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Godny*1,2, L. Reshef3, T. Pfeffer-Gik1,2, K. Rabinowitz1,2, I. Goren1,2, K. Yadgar1, K. Zonensain1, R. Barkan1, H. Yanai1,2, U. Gophna3, H. Tulchinsky4, I. Dotan1,2

Created: Friday, 22 February 2019, 9:41 AM
P840: IBD-related malignancies and mortalities observed in 2015–2017: 3 years’ results from the prospective nationwide Hungarian registry
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Molnar1*, F. Nagy1, P. Fritz2, L. Lakatos3, Z. Erdélyi3, P. Miheller4, T. Szamosi5, E. Schafer5, A. Vincze6, P. Sarlós6, J. Banai5, A. Kovács7, J. Novák8, A. Salamon9, A. Szepes10, N. Szigeti11, M. Juhász4, K. Müllner4, Z. Barta12, O. Kadenczki12, A. Gelley13, K. Palatka14, M. Papp12, A. Zaránd15, P. Lakatos16, G. Veres17, M. Rutka1, A. Balint1, R. Bor1, A. Milassin1, A. Fábián1, Z. Szepes1, K. Farkas1

Created: Thursday, 21 February 2019, 9:14 AM